ERBB2 and breast cancer: Furthermore, the application of FASN inhibitors (such as cerulenin) in BC has been reported to increase apoptosis in HER2-amplified BC cells, suggesting that the effect of FASN inhibitors on HER2 expression could be an effective therapeutic target for BC [161].